In addition to providing energy for the colonocytes, butyrate can suppress NF-κB transcription factor activation and interferon gamma and upregulate PPARγ, which thus withstand colorectal cancer and inflammatory bowel diseases [43,44,45,46,47]. Here, NFKB1 is linked to colorectal cancer.